Calix Inc

CALX remains in a Stage 4 decline with a recent support failure under the prior $36 cluster, confirming supply dominance. Price is extended below the 9/20/50 EMA complex with no exhaustion signals, making immediate sell execution suboptimal. Medium‐term bias is bearish, but execution should be deferred until rallies into the declining EMA zone around $36–$38 for optimal rejection entries.

• ↑Q2’26 revenue reached $293M, up 21% YoY and 5% sequentially.
• ↑Software & services revenue hit $50M, a 16% YoY rise led by AI workflows.
• ↓Q2 appliance gross margin slid 460 bps due to rising memory costs.